Page last updated: 2024-10-31

metyrapone and Neoplasms, Vascular

metyrapone has been researched along with Neoplasms, Vascular in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sanno, N1
Tahara, S1
Yoshida, Y1
Onose, H1
Wakabayashi, I1
Teramoto, A1

Other Studies

1 other study available for metyrapone and Neoplasms, Vascular

ArticleYear
Ectopic corticotroph adenoma in the cavernous sinus: case report.
    Neurosurgery, 1999, Volume: 45, Issue:4

    Topics: ACTH Syndrome, Ectopic; Cavernous Sinus; Death, Sudden; Dura Mater; Female; Humans; Magnetic Resonan

1999